These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 11224828)

  • 1. Oral oseltamivir treatment of influenza in children.
    Whitley RJ; Hayden FG; Reisinger KS; Young N; Dutkowski R; Ipe D; Mills RG; Ward P
    Pediatr Infect Dis J; 2001 Feb; 20(2):127-33. PubMed ID: 11224828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.
    Treanor JJ; Hayden FG; Vrooman PS; Barbarash R; Bettis R; Riff D; Singh S; Kinnersley N; Ward P; Mills RG
    JAMA; 2000 Feb; 283(8):1016-24. PubMed ID: 10697061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.
    Nicholson KG; Aoki FY; Osterhaus AD; Trottier S; Carewicz O; Mercier CH; Rode A; Kinnersley N; Ward P
    Lancet; 2000 May; 355(9218):1845-50. PubMed ID: 10866439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized, placebo-controlled multicenter study of oseltamivir phosphate for treatment of influenza infection in China.
    Li L; Cai B; Wang M; Zhu Y
    Chin Med J (Engl); 2003 Jan; 116(1):44-8. PubMed ID: 12667386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A multicenter study of efficacy and safety of oseltamivir in treatment of naturally acquired influenza].
    Li L; Cai B; Wang M; Zhu Y
    Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):838-42. PubMed ID: 16206676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral oseltamivir improves pulmonary function and reduces exacerbation frequency for influenza-infected children with asthma.
    Johnston SL; Ferrero F; Garcia ML; Dutkowski R
    Pediatr Infect Dis J; 2005 Mar; 24(3):225-32. PubMed ID: 15750458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0-9 years of age hospitalized with influenza in El Salvador and Panama.
    Dawood FS; Jara J; Gonzalez R; Castillo JM; De León T; Estripeaut D; Luciani K; Sujey Brizuela Y; Barahona A; Cazares RA; Lawson AM; Rodriguez M; de Viana D; Franco D; Castillo M; Fry AM; Gubareva L; Tamura D; Hughes M; Gargiullo P; Clara W; Azziz-Baumgartner E; Widdowson MA
    Antiviral Res; 2016 Sep; 133():85-94. PubMed ID: 27451343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population].
    Lin JT; Yu XZ; Cui DJ; Chen XY; Zhu JH; Wang YZ; Wu XD; Gao H; Huo ZL; Zhu SH; Hu SL; Wang AX
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):455-9. PubMed ID: 15312558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early administration of oral oseltamivir increases the benefits of influenza treatment.
    Aoki FY; Macleod MD; Paggiaro P; Carewicz O; El Sawy A; Wat C; Griffiths M; Waalberg E; Ward P;
    J Antimicrob Chemother; 2003 Jan; 51(1):123-9. PubMed ID: 12493796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children.
    Oo C; Barrett J; Hill G; Mann J; Dorr A; Dutkowski R; Ward P
    Paediatr Drugs; 2001; 3(3):229-36. PubMed ID: 11310719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oseltamivir: a review of its use in influenza.
    McClellan K; Perry CM
    Drugs; 2001; 61(2):263-83. PubMed ID: 11270942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
    Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.
    Hayden FG; Treanor JJ; Fritz RS; Lobo M; Betts RF; Miller M; Kinnersley N; Mills RG; Ward P; Straus SE
    JAMA; 1999 Oct; 282(13):1240-6. PubMed ID: 10517426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
    Ison MG; Szakaly P; Shapira MY; Kriván G; Nist A; Dutkowski R
    Antivir Ther; 2012; 17(6):955-64. PubMed ID: 22728756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza--placebo-controlled double-blind multicenter phase III trial].
    Kashiwagi S; Kudoh S; Watanabe A; Yoshimura I
    Kansenshogaku Zasshi; 2000 Dec; 74(12):1044-61. PubMed ID: 11193557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza--placebo-controlled double-blind multicenter phase III trial].
    Kashiwagi S; Kudoh S; Watanabe A; Yoshimura I
    Kansenshogaku Zasshi; 2000 Dec; 74(12):1062-76. PubMed ID: 11193558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.
    Hayden FG; Sugaya N; Hirotsu N; Lee N; de Jong MD; Hurt AC; Ishida T; Sekino H; Yamada K; Portsmouth S; Kawaguchi K; Shishido T; Arai M; Tsuchiya K; Uehara T; Watanabe A;
    N Engl J Med; 2018 Sep; 379(10):913-923. PubMed ID: 30184455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population.
    Peters PH; Gravenstein S; Norwood P; De Bock V; Van Couter A; Gibbens M; von Planta TA; Ward P
    J Am Geriatr Soc; 2001 Aug; 49(8):1025-31. PubMed ID: 11555062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.